Advertisement

Control of Maturity-Onset Diabetes by Monitoring Fasting Blood Glucose and Body Weight

  1. S Howe-Davies,
  2. R W Simpson and
  3. R C Turner
  1. Diabetes Research Laboratories, Nuffield Department of Clinical Medicine, Radcliffe Infirmary Oxford
  1. Address reprint requests to R. C. Turner, Diabetes Research Laboratories, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Abstract

The feasibility of reducing the fasting blood glucose (FBG) level to <6 mmol/L has been studied in all 84 maturity-onset diabetic (MOD) patients in three general practices. Only 35 (48%) were initially “well controlled” by this criterion, although 72 (86%) had no postprandial glycosuria. Seventy-one patients were monitored for 6 mo. With additional oral hypoglycemic therapy where necessary, the number of “well controlled” increased from 29 (41%) to 54 (76%), associated with a significant decrease in the hemoglobin A1. The patients were subsequently assessed at two 3-monthly intervals, and a fasting plasma glucose >4 and <6 mmol/L was usually maintained. All but two patients with a fasting glucose level < 6 mmol/L had fasting triglyceride concentrations < 2 mmol/L. The fasting blood glucose can be assayed in general practice with glucose-oxidase strips, and control by this means is simpler, cheaper, and more effective than regular urine glucose monitoring.

| Table of Contents
Advertisement